Scholarlink

Background <p>Metabolic acidosis is common after kidney transplantation and has been linked to adverse graft outcomes, but its potential contribution to functional decline has not been prospectively evaluated. We investigated whether persistent metabolic acidosis is associated with longitudinal frailty trajectories in kidney transplant recipients.</p> Methods <p>In this prospective single-center cohort study, 239 adult kidney transplant recipients were followed for 24 months. Serum bicarbonate was measured at baseline, 6, 12, and 24 months, and acidosis persistence was defined by the number of visits with bicarbonate &lt; 22 mmol/L (none, transient, recurrent, or persistent). Frailty was assessed using the Fried phenotype at baseline, 12 months, and 24 months. Longitudinal frailty trajectories were analyzed using mixed-effects ordinal logistic regression.</p> Results <p>Frailty prevalence at 24 months increased progressively with greater acidosis persistence, from 7.4% in patients without acidosis to 27.4% among those with persistent acidosis (p for trend = 0.004). In mixed-effects models, increasing acidosis persistence was associated with higher odds of worse frailty category (unadjusted proportional OR [pOR] per category 1.91, 95% CI 1.42–2.56). This association remained significant after adjustment for demographic, transplant-related, and clinical variables (pOR 1.52, 95% CI 1.12–2.06) and after additional adjustment for time-varying kidney function (pOR 1.42, 95% CI 1.04–1.95). Persistent acidosis was also associated with higher frailty scores in linear mixed models (β 0.31 per category increase, <i>p</i> &lt; 0.001).</p> Conclusion <p>Persistent metabolic acidosis was associated with worsening frailty trajectories after kidney transplantation, suggesting that persistent low bicarbonate may represent a clinically relevant marker of functional decline, although causality cannot be established.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Persistent metabolic acidosis and frailty trajectories after kidney transplantation: a prospective cohort study

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年7月27日

查看全文
  • Lucian Siriteanu,
  • Andreea Covic,
  • Călin Namolovan,
  • Simona Mihaela Hogaș,
  • Luminița Voroneanu,
  • Adrian Covic

摘要

Background

Metabolic acidosis is common after kidney transplantation and has been linked to adverse graft outcomes, but its potential contribution to functional decline has not been prospectively evaluated. We investigated whether persistent metabolic acidosis is associated with longitudinal frailty trajectories in kidney transplant recipients.

Methods

In this prospective single-center cohort study, 239 adult kidney transplant recipients were followed for 24 months. Serum bicarbonate was measured at baseline, 6, 12, and 24 months, and acidosis persistence was defined by the number of visits with bicarbonate < 22 mmol/L (none, transient, recurrent, or persistent). Frailty was assessed using the Fried phenotype at baseline, 12 months, and 24 months. Longitudinal frailty trajectories were analyzed using mixed-effects ordinal logistic regression.

Results

Frailty prevalence at 24 months increased progressively with greater acidosis persistence, from 7.4% in patients without acidosis to 27.4% among those with persistent acidosis (p for trend = 0.004). In mixed-effects models, increasing acidosis persistence was associated with higher odds of worse frailty category (unadjusted proportional OR [pOR] per category 1.91, 95% CI 1.42–2.56). This association remained significant after adjustment for demographic, transplant-related, and clinical variables (pOR 1.52, 95% CI 1.12–2.06) and after additional adjustment for time-varying kidney function (pOR 1.42, 95% CI 1.04–1.95). Persistent acidosis was also associated with higher frailty scores in linear mixed models (β 0.31 per category increase, p < 0.001).

Conclusion

Persistent metabolic acidosis was associated with worsening frailty trajectories after kidney transplantation, suggesting that persistent low bicarbonate may represent a clinically relevant marker of functional decline, although causality cannot be established.